Lifeboat Foundation

A breakthrough stem cell treatment that promises the first effective cure for heart disease will be offered to British patients this year, The Sunday Telegraph can reveal.

Hundreds of thousands stand to benefit after regulators approved a major trial of the regenerative drug capable of shrinking fatal scar tissue which follows a heart attack.

The “off-the-shelf” therapy, which can be harvested for thousands of recipients from one healthy donor, will begin being administered to patients at London’s Royal Brompton Hospital in November.

Continue reading “Heart disease stem cell therapy can shrink deadly scar tissue” »

http://www.thepathmag.com/can-you-actually-hack-your-dna-to-slow-down-aging/

Many technologies / interventions progressing down the development pathways in the coming years — but there are a lot of free, common sense adjustments you can make today:

M en with previously “untreatable” prostate cancer are being kept alive by a new drug in what experts believe may be a breakthrough for patients with the worst form of the disease.

A British trial has for the first time shown that state-of-the art immunotherapy can be used to target prostate tumours.

The study at the Royal Marsden Hospital in London found more than a third of men who had run out of existing options were still alive and one in ten had not seen their tumours grow after a year of taking Pembrolizumab, which targets a gateway helps the immune system to attack cancer cells.

Next week’s proposals are unlikely to contain major surprises, because the commission has unveiled its main ideas over the past months, in particular its overall 7-year budget plan, issued on 2 May. Although Horizon Europe will keep Horizon 2020’s main features, the commission has laid the groundwork for several novelties, including a new agency to tackle the continent’s perennial innovation problem and a big, separate push on collaborative defense research. But contentious negotiations lie ahead. The United Kingdom is negotiating the terms of its impending exit from the European Union, and some member states want to tighten budgets. Meanwhile, research advocates want more generous spending, noting the low application success rates in Horizon 2020—a frustrating 11.9% so far.

Commission seeks €97.6 billion for “Horizon Europe”.

A new wonderful breakthrough of our time.

Scientists raise ethical concerns as the brain cells of decapitated pigs are kept alive for 36 hours.

The development of Israel-based Urban Aeronautics’ Cormorant prototype is well underway, with hopes of launching a full-scale development of the aircraft in the near future.

DeepMind’s latest breakthrough could change our understanding of both AI and the way mammal’s brains work. A spontaneous development in the company’s neural network could solve neuron-based mystery.

The Vision Fund model is disruptive, then. But is it good for innovation and consumers? Mr Son’s project certainly has its attractions. It is shaking up the cosy world of Silicon Valley venture capital. And it may nurture competition against the tech giants. The fund offers founders of startups an alternative to cashing out to the likes of Google, Facebook and Amazon; its massive chequebook also gives those entrepreneurs a better shot at competing with the titans. The fund may perform a similar function in China, where nearly half of all unicorns are by now backed by one of the country’s four tech giants, Baidu, Alibaba, Tencent or

京东JD.COM-专业的综合网上购物商城,销售家电、数码通讯、电脑、家居百货、服装服饰、母婴、图书、食品等数万个品牌优质商品.便捷、诚信的服务，为您提供愉悦的网上购物体验!

Science fiction is powerful because it brings the future to life. Using a methodology called SciFi D.I., we can leverage science fiction to look 10 to 15 years into the future to redefine what’s possible today. When we can clearly imagine what the future might be like, we can begin to see a path to it.